Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

NCT03667443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-07-11

No results posted yet for this study

Summary

The investigator's aim is to evaluate if the combination of myo-inositol and alpha-lactalbumin can overcome the resistance to myo-inositol in PCOS patients

Conditions

  • PCOS
  • Myo-inositol-resistance

Interventions

DIETARY_SUPPLEMENT

Myo-inositol + folic a. + α-lactalbumin

3 months of treatment

DIETARY_SUPPLEMENT

Myo-inositol + folic a.

3 months of treatment

Sponsors & Collaborators

  • Lo.Li.Pharma s.r.l

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-13
Primary Completion
2022-10-26
Completion
2022-12-19

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667443 on ClinicalTrials.gov